Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NCDRC slaps...

    NCDRC slaps compensation on Insurance Co for denying medical claim

    Written by savita thakur thakur Published On 2016-08-19T13:31:10+05:30  |  Updated On 19 Aug 2016 1:31 PM IST
    NCDRC slaps compensation on Insurance Co for denying medical claim

    New Delhi : A District Consumer Disputes Redressal Forum here has directed an insurance company to compensate a woman for denying her mediclaim of Rs 64,705, observing that the rejection was unwarranted and devoid of merit.


    "When the treatment is undertaken by the unfortunate insured, the insurance company takes a somersault and immediately takes up the terms and conditions of the policy which admittedly were not supplied to the insured at the time of inception of the policy," the forum observed while awarding Rs 8,000 compensation to north Delhi resident Vandana Dalmia.


    "The insured feels cheated at the hands of insurance company," the forum headed by President K S Mohi said.


    "The insured seldom gets the terms and conditions at the time of inception of the policy or any subsequent thereto. But the insurance companies, in order to evade their liability, press into service their terms and conditions when the claim is filed," the forum, also comprising members Subhash Gupta and Shahina, observed.


    "We are of the considered view that the repudiation of claim of the insured by the insurance company were wholly unwarranted and devoid of any merit and therefore, it constituted deficiency in service," it said.


    It also directed the award of Rs 64,705 with interest at the rate of 6 per cent from the date institution of the complaint till payment, besides another Rs 8,000 towards harassment mental agony loss of time and litigation cost.


    According to the complaint, Dalmia was admitted to a hospital for liver-related (Lap Cholecystectomy) treatment on February 7, 2011 which cost her Rs 64,705.


    However, the medical claim towards her hospitalisation and treatment was rejected by Oriental Insurance Company Ltd, saying as per the terms and conditions of the policy taken by Dalmia, the disease suffered by her could not be covered in the first year of the policy.


    Dalmia further alleged that the insurance company while issuing the policy had never apprised her about any such condition and had not even supplied the policy with alleged conditions and clauses as they were claiming.


    The insurance company claimed that as per terms and conditions of the policy, they were not liable for any claim and prayed for the dismissal of the complaint.


    "The insurance company has miserably failed to establish as to by which mode (it had) supplied the terms and conditions to the insured. The law is now well settled which lays down that the insurance company cannot take shelter under the umbrella of terms and conditions unless the same were duly furnished to the insured," the forum observed.

    compensationDistrict Consumer Disputes Redressal ForumMedical ClaimOriental Insurance Company LimitedSubhash GuptaVandana Dalmia
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok